questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Glycoprotéines membranaires
Glycoprotéines membranaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Gain of Function Mutation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Glycoprotéines membranaires : Questions médicales les plus fréquentes",
"headline": "Glycoprotéines membranaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Glycoprotéines membranaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-03",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Glycoprotéines membranaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines membranaires",
"url": "https://questionsmedicales.fr/mesh/D008565",
"about": {
"@type": "MedicalCondition",
"name": "Protéines membranaires",
"code": {
"@type": "MedicalCode",
"code": "D008565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigène AC133",
"alternateName": "AC133 Antigen",
"url": "https://questionsmedicales.fr/mesh/D000071916",
"about": {
"@type": "MedicalCondition",
"name": "Antigène AC133",
"code": {
"@type": "MedicalCode",
"code": "D000071916",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.023"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD38",
"alternateName": "ADP-ribosyl Cyclase 1",
"url": "https://questionsmedicales.fr/mesh/D051997",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD38",
"code": {
"@type": "MedicalCode",
"code": "D051997",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.045"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD47",
"alternateName": "CD47 Antigen",
"url": "https://questionsmedicales.fr/mesh/D051928",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD47",
"code": {
"@type": "MedicalCode",
"code": "D051928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.147"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD58",
"alternateName": "CD58 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018968",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD58",
"code": {
"@type": "MedicalCode",
"code": "D018968",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.158"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Butyrophilines",
"alternateName": "Butyrophilins",
"url": "https://questionsmedicales.fr/mesh/D000071797",
"about": {
"@type": "MedicalCondition",
"name": "Butyrophilines",
"code": {
"@type": "MedicalCode",
"code": "D000071797",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.195"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines liées au GPI",
"alternateName": "GPI-Linked Proteins",
"url": "https://questionsmedicales.fr/mesh/D058851",
"about": {
"@type": "MedicalCondition",
"name": "Protéines liées au GPI",
"code": {
"@type": "MedicalCode",
"code": "D058851",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD55",
"alternateName": "CD55 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018958",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD55",
"code": {
"@type": "MedicalCode",
"code": "D018958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.130"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD59",
"alternateName": "CD59 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018957",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD59",
"code": {
"@type": "MedicalCode",
"code": "D018957",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.140"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène stromal-2 de la moëlle osseuse",
"alternateName": "Bone Marrow Stromal Antigen 2",
"url": "https://questionsmedicales.fr/mesh/D000074010",
"about": {
"@type": "MedicalCondition",
"name": "Antigène stromal-2 de la moëlle osseuse",
"code": {
"@type": "MedicalCode",
"code": "D000074010",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Carbonic anhydrase-IV",
"alternateName": "Carbonic Anhydrase IV",
"url": "https://questionsmedicales.fr/mesh/D030741",
"about": {
"@type": "MedicalCondition",
"name": "Carbonic anhydrase-IV",
"code": {
"@type": "MedicalCode",
"code": "D030741",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.160"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glypicanes",
"alternateName": "Glypicans",
"url": "https://questionsmedicales.fr/mesh/D053673",
"about": {
"@type": "MedicalCondition",
"name": "Glypicanes",
"code": {
"@type": "MedicalCode",
"code": "D053673",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 17",
"alternateName": "Matrix Metalloproteinase 17",
"url": "https://questionsmedicales.fr/mesh/D053515",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 17",
"code": {
"@type": "MedicalCode",
"code": "D053515",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uromoduline",
"alternateName": "Uromodulin",
"url": "https://questionsmedicales.fr/mesh/D058949",
"about": {
"@type": "MedicalCondition",
"name": "Uromoduline",
"code": {
"@type": "MedicalCode",
"code": "D058949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.850"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Glycoprotéines de membrane associées au lysosome",
"alternateName": "Lysosome-Associated Membrane Glycoproteins",
"url": "https://questionsmedicales.fr/mesh/D051907",
"about": {
"@type": "MedicalCondition",
"name": "Glycoprotéines de membrane associées au lysosome",
"code": {
"@type": "MedicalCode",
"code": "D051907",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.527"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine de membrane-2 associée au lysosome",
"alternateName": "Lysosomal-Associated Membrane Protein 2",
"url": "https://questionsmedicales.fr/mesh/D052119",
"about": {
"@type": "MedicalCondition",
"name": "Protéine de membrane-2 associée au lysosome",
"code": {
"@type": "MedicalCode",
"code": "D052119",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.527.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 de membrane associée au lysosome",
"alternateName": "Lysosomal-Associated Membrane Protein 3",
"url": "https://questionsmedicales.fr/mesh/D059666",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 de membrane associée au lysosome",
"code": {
"@type": "MedicalCode",
"code": "D059666",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.527.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Mucine-3",
"alternateName": "Mucin-3",
"url": "https://questionsmedicales.fr/mesh/D055263",
"about": {
"@type": "MedicalCondition",
"name": "Mucine-3",
"code": {
"@type": "MedicalCode",
"code": "D055263",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.542"
}
}
},
{
"@type": "MedicalWebPage",
"name": "PHEX Phosphate regulating neutral endopeptidase",
"alternateName": "PHEX Phosphate Regulating Neutral Endopeptidase",
"url": "https://questionsmedicales.fr/mesh/D053402",
"about": {
"@type": "MedicalCondition",
"name": "PHEX Phosphate regulating neutral endopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D053402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.607"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sarcoglycanes",
"alternateName": "Sarcoglycans",
"url": "https://questionsmedicales.fr/mesh/D049031",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoglycanes",
"code": {
"@type": "MedicalCode",
"code": "D049031",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.712"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndécanes",
"alternateName": "Syndecans",
"url": "https://questionsmedicales.fr/mesh/D053667",
"about": {
"@type": "MedicalCondition",
"name": "Syndécanes",
"code": {
"@type": "MedicalCode",
"code": "D053667",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndécane-1",
"alternateName": "Syndecan-1",
"url": "https://questionsmedicales.fr/mesh/D053668",
"about": {
"@type": "MedicalCondition",
"name": "Syndécane-1",
"code": {
"@type": "MedicalCode",
"code": "D053668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndécane-2",
"alternateName": "Syndecan-2",
"url": "https://questionsmedicales.fr/mesh/D053669",
"about": {
"@type": "MedicalCondition",
"name": "Syndécane-2",
"code": {
"@type": "MedicalCode",
"code": "D053669",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndécane-3",
"alternateName": "Syndecan-3",
"url": "https://questionsmedicales.fr/mesh/D053670",
"about": {
"@type": "MedicalCondition",
"name": "Syndécane-3",
"code": {
"@type": "MedicalCode",
"code": "D053670",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndécane-4",
"alternateName": "Syndecan-4",
"url": "https://questionsmedicales.fr/mesh/D053671",
"about": {
"@type": "MedicalCondition",
"name": "Syndécane-4",
"code": {
"@type": "MedicalCode",
"code": "D053671",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thrombospondines",
"alternateName": "Thrombospondins",
"url": "https://questionsmedicales.fr/mesh/D019699",
"about": {
"@type": "MedicalCondition",
"name": "Thrombospondines",
"code": {
"@type": "MedicalCode",
"code": "D019699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.895"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thrombospondine-1",
"alternateName": "Thrombospondin 1",
"url": "https://questionsmedicales.fr/mesh/D019700",
"about": {
"@type": "MedicalCondition",
"name": "Thrombospondine-1",
"code": {
"@type": "MedicalCode",
"code": "D019700",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.895.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Uroplakines",
"alternateName": "Uroplakins",
"url": "https://questionsmedicales.fr/mesh/D060165",
"about": {
"@type": "MedicalCondition",
"name": "Uroplakines",
"code": {
"@type": "MedicalCode",
"code": "D060165",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.942"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Uroplakine II",
"alternateName": "Uroplakin II",
"url": "https://questionsmedicales.fr/mesh/D060170",
"about": {
"@type": "MedicalCondition",
"name": "Uroplakine II",
"code": {
"@type": "MedicalCode",
"code": "D060170",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.942.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uroplakine III",
"alternateName": "Uroplakin III",
"url": "https://questionsmedicales.fr/mesh/D060171",
"about": {
"@type": "MedicalCondition",
"name": "Uroplakine III",
"code": {
"@type": "MedicalCode",
"code": "D060171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.942.300"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Glycoprotéines membranaires",
"alternateName": "Membrane Glycoproteins",
"code": {
"@type": "MedicalCode",
"code": "D008562",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yang Liu",
"url": "https://questionsmedicales.fr/author/Yang%20Liu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430207, China."
}
},
{
"@type": "Person",
"name": "Hanh T Nguyen",
"url": "https://questionsmedicales.fr/author/Hanh%20T%20Nguyen",
"affiliation": {
"@type": "Organization",
"name": "Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA."
}
},
{
"@type": "Person",
"name": "Pablo Guardado-Calvo",
"url": "https://questionsmedicales.fr/author/Pablo%20Guardado-Calvo",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France."
}
},
{
"@type": "Person",
"name": "Félix A Rey",
"url": "https://questionsmedicales.fr/author/F%C3%A9lix%20A%20Rey",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France. Electronic address: felix.rey@pasteur.fr."
}
},
{
"@type": "Person",
"name": "Cheng Man Lun",
"url": "https://questionsmedicales.fr/author/Cheng%20Man%20Lun",
"affiliation": {
"@type": "Organization",
"name": "Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation.",
"datePublished": "2022-08-24",
"url": "https://questionsmedicales.fr/article/36028086",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmi.2022.08.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations.",
"datePublished": "2024-08-23",
"url": "https://questionsmedicales.fr/article/39177867",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10875-024-01776-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "A gain of function ryanodine receptor 2 mutation (R1760W-RyR2) in catecholaminergic polymorphic ventricular tachycardia.",
"datePublished": "2022-10-02",
"url": "https://questionsmedicales.fr/article/36082968",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1440-1681.13722"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel gain-of-function PIP4K2A mutation elevates the expression of β-globin and aggravates the severity of α-thalassemia.",
"datePublished": "2023-07-09",
"url": "https://questionsmedicales.fr/article/37423903",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bjh.18967"
}
},
{
"@type": "ScholarlyArticle",
"name": "Chinese Pedigree of Chronic Mucocutaneous Candidiasis Due to STAT1 Gain-of-Function Mutation: A Case Study and Literature Review.",
"datePublished": "2022-11-06",
"url": "https://questionsmedicales.fr/article/36335528",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11046-022-00685-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Glycoprotéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008562"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Glycoprotéines membranaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Glycoprotéines membranaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Glycoprotéines membranaires",
"description": "Comment diagnostiquer une anomalie des glycoprotéines membranaires ?\nQuels tests sont utilisés pour évaluer les glycoprotéines ?\nLes tests génétiques sont-ils utiles pour les glycoprotéines ?\nQuels marqueurs sont associés aux glycoprotéines ?\nLes imageries médicales aident-elles au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Gain+of+Function+Mutation&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Glycoprotéines membranaires",
"description": "Quels symptômes indiquent un problème de glycoprotéines ?\nLes troubles neurologiques sont-ils liés aux glycoprotéines ?\nPeut-on observer des symptômes cutanés ?\nLes troubles respiratoires sont-ils associés aux glycoprotéines ?\nLes symptômes digestifs peuvent-ils être liés ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Gain+of+Function+Mutation&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Glycoprotéines membranaires",
"description": "Comment prévenir les troubles liés aux glycoprotéines ?\nLes vaccinations sont-elles importantes ?\nLe dépistage précoce est-il recommandé ?\nLes habitudes de vie influencent-elles la santé des glycoprotéines ?\nL'éducation à la santé est-elle cruciale ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Gain+of+Function+Mutation&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Glycoprotéines membranaires",
"description": "Quels traitements ciblent les anomalies glycoprotéiques ?\nLes traitements biologiques sont-ils efficaces ?\nLa nutrition joue-t-elle un rôle dans le traitement ?\nLes thérapies physiques sont-elles bénéfiques ?\nLes médicaments anti-inflammatoires sont-ils utilisés ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Gain+of+Function+Mutation&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Glycoprotéines membranaires",
"description": "Quelles complications peuvent survenir avec des anomalies glycoprotéiques ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications cardiovasculaires sont-elles possibles ?\nLes complications infectieuses sont-elles liées ?\nLes complications métaboliques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Gain+of+Function+Mutation&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Glycoprotéines membranaires",
"description": "Quels facteurs de risque sont associés aux anomalies glycoprotéiques ?\nLe mode de vie influence-t-il les glycoprotéines ?\nLes maladies chroniques sont-elles un facteur de risque ?\nL'exposition à des toxines est-elle un risque ?\nLe stress a-t-il un impact sur les glycoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Gain+of+Function+Mutation&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des glycoprotéines membranaires ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies peuvent révéler des anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les glycoprotéines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électrophorèse et la chromatographie sont couramment utilisés pour l'évaluation."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les glycoprotéines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant les glycoprotéines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux glycoprotéines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme les antigènes peuvent indiquer des anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Les imageries médicales aident-elles au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines imageries peuvent montrer des changements cellulaires liés aux glycoprotéines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de glycoprotéines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'inflammation ou des troubles immunitaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés aux glycoprotéines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines glycoprotéines sont impliquées dans des maladies neurologiques."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes cutanés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent être liées à des anomalies des glycoprotéines."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils associés aux glycoprotéines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines glycoprotéines peuvent affecter la fonction pulmonaire et causer des troubles."
}
},
{
"@type": "Question",
"name": "Les symptômes digestifs peuvent-ils être liés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies glycoprotéiques peuvent entraîner des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux glycoprotéines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces troubles."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections affectant les glycoprotéines."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage peut aider à identifier les anomalies glycoprotéiques tôt."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles la santé des glycoprotéines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes saines peuvent améliorer la santé cellulaire et glycoprotéique."
}
},
{
"@type": "Question",
"name": "L'éducation à la santé est-elle cruciale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sensibiliser à la santé peut aider à prévenir les troubles liés aux glycoprotéines."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les anomalies glycoprotéiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des médicaments immunomodulateurs peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements biologiques sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements biologiques peuvent cibler spécifiquement les glycoprotéines."
}
},
{
"@type": "Question",
"name": "La nutrition joue-t-elle un rôle dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en nutriments peut soutenir la fonction des glycoprotéines."
}
},
{
"@type": "Question",
"name": "Les thérapies physiques sont-elles bénéfiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent aider à améliorer la fonction cellulaire et réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Les médicaments anti-inflammatoires sont-ils utilisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire l'inflammation liée aux anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies glycoprotéiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des maladies auto-immunes ou des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent être des complications des anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles possibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies glycoprotéiques peuvent augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications infectieuses sont-elles liées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies glycoprotéiques peuvent rendre les cellules plus vulnérables aux infections."
}
},
{
"@type": "Question",
"name": "Les complications métaboliques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies glycoprotéiques peuvent entraîner des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux anomalies glycoprotéiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, la génétique et l'environnement peuvent influencer les anomalies."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il les glycoprotéines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut augmenter le risque d'anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies chroniques peuvent prédisposer à des anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines peut affecter la structure des glycoprotéines."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les glycoprotéines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut influencer la fonction des glycoprotéines et la santé cellulaire."
}
}
]
}
]
}
Hereby, we describe the molecular mechanisms underlying the acquisition of azole resistance by a Candida parapsilosis isolate following fluconazole treatment due to candiduria....
A set of three consecutive C. parapsilosis isolates were recovered from the urine samples of a patient with candiduria. Whole-genome sequencing and antifungal susceptibility assays were performed. The...
The initial isolate CPS-A was susceptible to all three azoles tested (fluconazole, voriconazole and posaconazole); isolate CPS-B, collected after the second cycle of treatment, exhibited a susceptible...
Our results describe clinical azole cross-resistance acquisition in C. parapsilosis due to a G1810A (G604R) gain-of-function mutation, resulting in MRR1 hyperactivation and consequently, MDR1 efflux p...
Heterozygous STAT1 Gain-of-Function (GOF) mutations are the most common cause of chronic mucocutaneous candidiasis (CMC) among Inborn Errors of Immunity. Clinically, these mutations manifest as a broa...
We analyzed clinical presentations, cellular phenotypes, and functional impacts in five Taiwanese patients with STAT1 GOF....
We identified two novel GOF mutations in 5 patients from 2 Taiwanese families, presenting with symptoms of CMC, late-onset rosacea, and autoimmunity. The enhanced phosphorylation and delayed dephospho...
Our study provides the first comprehensive clinical and molecular characteristics in STAT1 GOF patient in Taiwan and highlights the dysregulated T and B cells subsets which may hinge the autoimmunity ...
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome associated with Ca...
Haemoglobin H (Hb H) disease (intermediate status of α-thalassemia) shows marked phenotypic variability from asymptomatic to severe anaemia. Apart from the combined β-thalassemia allele ameliorating c...
To further elucidate the clinical, immunological and genetic features of chronic mucocutaneous candidiasis (CMC) due to STAT1 GOF mutation in the Chinese population....
Clinical data for a proband were collected, and pedigree analyses were performed. Whole-exome sequencing and targeted Sanger sequencing were conducted to explore genetic factors of a Chinese pedigree ...
An autosomal dominant CMC pedigree was identified, and both the proband and his father had mucocutaneous Candida infections without involvement of other systems. A rare mutation (c.T1175C) in STAT1 wa...
STAT1 GOF mutation at c.T1175C (p.M392T) may lead to mucocutaneous Candida infections and an increase in serum IFN-α. T385M in the DNA-binding domain is the most common STAT1 GOF mutation found in the...
Although the molecular features of pancreatic ductal adenocarcinoma (PDAC) have been well described, the impact of detailed gene mutation subtypes on disease progression remained unclear. This study a...
We included 639 patients treated with PDAC in Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine between Jan 2019 and Jun 2021. The genomic alterations of PDAC were analyzed...
TP53 missense mutation was significantly associated with poor differentiation in KRAS...
TP53 missense mutation was associated with poor tumor differentiation, and revealed gain-of-function properties in small-sized KRAS transformed PDAC. Nonetheless, it was not associated with insensitiv...
We investigated an early adolescent female with intellectual disability, drug-responsive epilepsy and white matter abnormalities. Through exome sequencing, we identified the novel de novo variant (NM_...
In vitro analyses revealed that the p.F28S variant was spontaneously activated by substantially increased intrinsic GTP/GDP-exchange activity and bound to downstream effectors tested, such as PAK1 and...
Our results indicate that RAC3 is critical for brain development and the p.F28S variant causes morphological and functional defects in cortical neurons, likely due to the hyperactivation of PAK1....
Arthrogryposis multiplex congenita (AMC) is a group of clinically and etiologically heterogeneous conditions, characterized by prenatal onset contractures affecting two or more joints. Its incidence i...
Hereby, we report on a four-generation Italian family with DA5. Our first proband was a newborn with prenatal suspicion of AMC. At birth, clinical findings were compatible with a DA diagnosis. Family ...
Our patients contribute to the current DA5 genomic database, and to a better characterization of the disease. Clinicians may have suspicion of a DA diagnosis based on suggestive (also prenatal) clinic...
Polycomb repressive complex 2 (PRC2) suppresses gene transcription by methylating lysine 27 of histone H3 (H3K27) and plays critical roles in embryonic development. Among the core PRC2 subunits, EZH2 ...
Inherited autosomal dominant gain-of-function (GOF) mutations of signal transducer and activator of transcription 1 (STAT1) cause a wide range of symptoms affecting multiple systems, including chronic...